Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 21 studies | 56% ± 20% | |
peripheral blood | 21 studies | 40% ± 13% | |
intestine | 13 studies | 42% ± 18% | |
kidney | 8 studies | 38% ± 12% | |
eye | 6 studies | 32% ± 20% | |
uterus | 6 studies | 62% ± 18% | |
pancreas | 5 studies | 45% ± 19% | |
bone marrow | 5 studies | 33% ± 13% | |
heart | 5 studies | 30% ± 10% | |
adipose | 5 studies | 46% ± 19% | |
esophagus | 5 studies | 57% ± 25% | |
prostate | 5 studies | 71% ± 26% | |
skin | 5 studies | 61% ± 25% | |
breast | 5 studies | 60% ± 23% | |
placenta | 4 studies | 75% ± 29% | |
liver | 4 studies | 30% ± 6% | |
ovary | 3 studies | 33% ± 5% | |
adrenal gland | 3 studies | 39% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 46496.56 | 576 / 578 | 99% | 309.07 | 1149 / 1155 |
breast | 100% | 42897.88 | 459 / 459 | 99% | 231.89 | 1105 / 1118 |
esophagus | 99% | 53900.01 | 1433 / 1445 | 99% | 317.90 | 181 / 183 |
bladder | 100% | 27067.33 | 21 / 21 | 98% | 279.80 | 493 / 504 |
skin | 100% | 105190.97 | 1809 / 1809 | 97% | 216.38 | 457 / 472 |
intestine | 94% | 21974.64 | 912 / 966 | 99% | 271.62 | 524 / 527 |
uterus | 94% | 18606.56 | 159 / 170 | 98% | 362.64 | 451 / 459 |
thymus | 100% | 22546.86 | 650 / 653 | 90% | 172.15 | 546 / 605 |
stomach | 84% | 15174.04 | 302 / 359 | 99% | 225.14 | 284 / 286 |
kidney | 87% | 18414.51 | 77 / 89 | 95% | 146.38 | 852 / 901 |
ovary | 76% | 9309.92 | 137 / 180 | 99% | 162.26 | 425 / 430 |
prostate | 100% | 25066.60 | 245 / 245 | 67% | 58.04 | 337 / 502 |
pancreas | 70% | 9830.29 | 230 / 328 | 96% | 442.07 | 171 / 178 |
adrenal gland | 95% | 21113.41 | 244 / 258 | 43% | 35.37 | 98 / 230 |
adipose | 100% | 50291.61 | 1204 / 1204 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 194.43 | 1 / 1 |
blood vessel | 100% | 35301.51 | 1329 / 1335 | 0% | 0 | 0 / 0 |
spleen | 99% | 17794.41 | 239 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 353.21 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 96% | 151.79 | 77 / 80 |
liver | 23% | 3827.36 | 52 / 226 | 73% | 100.05 | 296 / 406 |
lymph node | 0% | 0 | 0 / 0 | 86% | 94.08 | 25 / 29 |
heart | 78% | 12509.38 | 675 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 63% | 8705.29 | 588 / 929 | 0% | 0 | 0 / 0 |
muscle | 59% | 8509.75 | 475 / 803 | 0% | 0 | 0 / 0 |
brain | 4% | 504.65 | 107 / 2642 | 32% | 44.76 | 228 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032804 | Biological process | negative regulation of low-density lipoprotein particle receptor catabolic process |
GO_1905581 | Biological process | positive regulation of low-density lipoprotein particle clearance |
GO_0001525 | Biological process | angiogenesis |
GO_0001921 | Biological process | positive regulation of receptor recycling |
GO_0030324 | Biological process | lung development |
GO_0031340 | Biological process | positive regulation of vesicle fusion |
GO_0010756 | Biological process | positive regulation of plasminogen activation |
GO_0007160 | Biological process | cell-matrix adhesion |
GO_0044090 | Biological process | positive regulation of vacuole organization |
GO_0014823 | Biological process | response to activity |
GO_0042730 | Biological process | fibrinolysis |
GO_1905597 | Biological process | positive regulation of low-density lipoprotein particle receptor binding |
GO_1905599 | Biological process | positive regulation of low-density lipoprotein receptor activity |
GO_0036035 | Biological process | osteoclast development |
GO_1905686 | Biological process | positive regulation of plasma membrane repair |
GO_0006900 | Biological process | vesicle budding from membrane |
GO_0042789 | Biological process | mRNA transcription by RNA polymerase II |
GO_1904019 | Biological process | epithelial cell apoptotic process |
GO_0002091 | Biological process | negative regulation of receptor internalization |
GO_0030199 | Biological process | collagen fibril organization |
GO_0050767 | Biological process | regulation of neurogenesis |
GO_1905602 | Biological process | positive regulation of receptor-mediated endocytosis involved in cholesterol transport |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0045921 | Biological process | positive regulation of exocytosis |
GO_0001765 | Biological process | membrane raft assembly |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0005615 | Cellular component | extracellular space |
GO_0030496 | Cellular component | midbody |
GO_0031902 | Cellular component | late endosome membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005811 | Cellular component | lipid droplet |
GO_0045121 | Cellular component | membrane raft |
GO_0012506 | Cellular component | vesicle membrane |
GO_0016020 | Cellular component | membrane |
GO_0005769 | Cellular component | early endosome |
GO_0042383 | Cellular component | sarcolemma |
GO_0070062 | Cellular component | extracellular exosome |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_1990667 | Cellular component | PCSK9-AnxA2 complex |
GO_0001533 | Cellular component | cornified envelope |
GO_0016363 | Cellular component | nuclear matrix |
GO_0043220 | Cellular component | Schmidt-Lanterman incisure |
GO_0009986 | Cellular component | cell surface |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005829 | Cellular component | cytosol |
GO_0098797 | Cellular component | plasma membrane protein complex |
GO_0005912 | Cellular component | adherens junction |
GO_0005737 | Cellular component | cytoplasm |
GO_0042470 | Cellular component | melanosome |
GO_0005604 | Cellular component | basement membrane |
GO_1990665 | Cellular component | AnxA2-p11 complex |
GO_0005768 | Cellular component | endosome |
GO_0031982 | Cellular component | vesicle |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0035749 | Cellular component | myelin sheath adaxonal region |
GO_0005634 | Cellular component | nucleus |
GO_0005544 | Molecular function | calcium-dependent phospholipid binding |
GO_0019834 | Molecular function | phospholipase A2 inhibitor activity |
GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0001786 | Molecular function | phosphatidylserine binding |
GO_0002020 | Molecular function | protease binding |
GO_0048306 | Molecular function | calcium-dependent protein binding |
GO_0098641 | Molecular function | cadherin binding involved in cell-cell adhesion |
GO_0003723 | Molecular function | RNA binding |
GO_0044548 | Molecular function | S100 protein binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0008092 | Molecular function | cytoskeletal protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ANXA2 |
Protein name | Annexin A2 Annexin Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36) |
Synonyms | hCG_2004404 LPC2D ANX2 ANX2L4 CAL1H |
Description | FUNCTION: Calcium-regulated membrane-binding protein whose affinity for calcium is greatly enhanced by anionic phospholipids. It binds two calcium ions with high affinity. May be involved in heat-stress response. Inhibits PCSK9-enhanced LDLR degradation, probably reduces PCSK9 protein levels via a translational mechanism but also competes with LDLR for binding with PCSK9 . .; FUNCTION: (Microbial infection) Binds M.pneumoniae CARDS toxin, probably serves as one receptor for this pathogen. When ANXA2 is down-regulated by siRNA, less toxin binds to human cells and less vacuolization (a symptom of M.pneumoniae infection) is seen. . |
Accessions | H0YL33 H0YNB8 ENST00000560389.5 ENST00000558986.5 ENST00000557906.6 [P07355-1] H0YKN4 ENST00000559370.5 ENST00000678870.1 [P07355-1] H0YMD9 ENST00000559725.5 H0YN42 H0YKS4 H0YKV8 ENST00000557904.5 ENST00000559350.5 ENST00000558558 ENST00000559467.5 H0YMD0 ENST00000421017.6 [P07355-1] ENST00000558132.5 ENST00000558985.6 ENST00000451270.7 [P07355-1] P07355 ENST00000557906 H0YMW4 H0YNP5 H0YM50 H0YKX9 ENST00000558558.6 [P07355-1] H0YLE2 ENST00000559176.5 ENST00000558169.6 H0YNA0 ENST00000560165.5 H0YMU9 ENST00000676687.1 ENST00000678061.1 [P07355-1] ENST00000559113.6 ENST00000560468 ENST00000560367.6 ENST00000559818 ENST00000396024.7 [P07355-1] A0A024R5Z7 ENST00000560466.5 ENST00000558998.5 ENST00000332680.8 [P07355-2] H0YKZ7 H0YMM1 H0YLV6 ENST00000560014.5 ENST00000561022.5 ENST00000559780.6 H0YMT9 ENST00000677968.1 [P07355-1] H0YKL9 A0A7I2V4P4 ENST00000559956 ENST00000558503.6 H0YN28 ENST00000560468.6 [P07355-1] ENST00000678450.1 [P07355-1] ENST00000559818.6 [P07355-1] ENST00000679109.1 [P07355-1] ENST00000559956.6 [P07355-1] |